Amgen
AMGN
1,595 hedge funds and large institutions have $99.6B invested in Amgen in 2017 Q2 according to their latest regulatory filings, with 93 funds opening new positions, 682 increasing their positions, 577 reducing their positions, and 84 closing their positions.
18% more repeat investments, than reductions
Existing positions increased: 682 | Existing positions reduced: 577
11% more first-time investments, than exits
New positions opened: 93 | Existing positions closed: 84
6% more funds holding in top 10
Funds holding in top 10: 79 → 84 (+5)
4% more capital invested
Capital invested by funds: $95.7B → $99.6B (+$3.82B)
0% less funds holding
Funds holding: 1,601 → 1,595 (-6)
0.62% less ownership
Funds ownership: 79.15% → 78.53% (-0.62%)
12% less call options, than puts
Call options by funds: $1.14B | Put options by funds: $1.31B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$586M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$421M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$347M |
| 4 |
Two Sigma Advisers
New York
|
+$271M |
| 5 |
Renaissance Technologies
New York
|
+$160M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$582M |
| 2 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
-$183M |
| 3 |
Primecap Management
Pasadena,
California
|
-$182M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$145M |
| 5 |
Barclays
London,
United Kingdom
|
-$138M |
AMGN Hedge Fund Activity: Q2 2017 in Review
1,595 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q2 2017, worth a combined $99.6B — up 4% from $95.7B a quarter earlier.
Buyers outnumbered sellers: 93 funds opened new AMGN positions and 84 closed out — a net gain of 9 holders — while 682 added to existing stakes and 577 trimmed.
The largest buyer was Janus Henderson Group, adding an estimated $586M. The largest seller was Capital Research Global Investors, cutting an estimated $582M.
- 1,595 institutional investors held Amgen (AMGN) as of Q2 2017, down from 1,601 in Q1 2017.
- Funds reported $99.6B of Amgen stock for Q2 2017, up 4% quarter-over-quarter.
- 93 funds opened new Amgen positions in Q2 2017 and 84 closed out, a net change of +9 holders.
- The largest Amgen buyer in Q2 2017 was Janus Henderson Group, an estimated $586M added.
- The largest Amgen seller in Q2 2017 was Capital Research Global Investors, an estimated $582M sold.
Based on aggregated 13F filings for Q2 2017.